AVRNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Anteris Technologies Global Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$6.18+0.13 (+2.15%)

Close on Oct 19, 2026

Market cap: $601.56M
P/E (TTM): –
Dividend yield: –

Anteris Technologies Global Corp. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31
Revenue	1.91	2.70
Cost of Revenue	0.57	1.44
Gross Profit	1.34	1.27
Research & Development	69	51
Selling, General & Admin	26	28
Operating Income	-94	-78
Interest Expense	0.07	0.05
Interest & Investment Income	0.71	0.43
Other Non-Operating Income	0.47	2.44
Pretax Income	-94	-76
Income Tax Expense	0	0
Net Income incl. Noncontrolling Interests	-94	-76
Minority Interest in Earnings	-0.08	0.32
Net Income	-94	-76
EPS (Basic)(per share)	-2.55	-3.68
EPS (Diluted)(per share)	-2.55	-3.68
Shares Outstanding (Basic, Weighted)(shares)	37	20
Shares Outstanding (Diluted, Weighted)(shares)	37	20
EBITDA	-92	-77

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 75.0%
Operating margin: -4738.4%
Net margin: -4619.3%
Return on equity, FY2025: -300.5%

Financial strength

Current ratio: 14.20
Debt to equity: 0.00
Debt to assets: 0.2%
Cash to current liabilities: 1361.1%

Valuation

P/E ratio: –
Price to sales: 268.32
Price to book: 2.39
Dividend yield: –